The committee will not be voting on the bill at the hearing, but prospects are not great as it makes what is likely to be its last attempt to address drug costs.
Read the full article here.
The committee will not be voting on the bill at the hearing, but prospects are not great as it makes what is likely to be its last attempt to address drug costs.
Read the full article here.